HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
Home » News » Study: High Prices May Not Translate to Better Care

Study: High Prices May Not Translate to Better Care

The old adage “you get what you pay for” doesn't neccesarily apply to healthcare, according to a recent study published in the National Bureau of Economic Research. The study examined employer sponsored insurance claims data from the Health Care Cost Initiative (HCCI) spanning from June 2007 to 2014. The results show that there are only specific conditions in which price scales with quality of care, as measured by patient outcomes.

According to Victoria Bailey of Revcycle Intelligence, “The researchers also noted the Herfindahl-Hirschman Index (HHI) of the hospitals, which measures market concentration. The mean hospital HHI was 4,327, while the HHI at the 25th and 75th percentiles were 2,344 and 5,422, respectively.The results revealed that hospitals with higher inpatient prices had a 35 percent reduction in in-hospital mortality, but only when the hospitals were in an unconcentrated market. In addition, each life saved at a high-priced hospital with an HHI of less than 4,000 costs an additional $1.09 million in health spending, which is significantly lower than the $8.7 million estimation from the Environmental Protection Agency, the study noted.”

Learn more about the study by clicking here

(Source Revcycle Intelligence, March 2nd, 2022)

You might be interested in:

  1. Patients Rising Initiative Issues Statement on Federal Healthcare Programs and Payer Coverage
  2. Healthcare Policy Experts Urge CMS to Quickly Move on Biogen’s Alzheimer’s Drug
  3. Understanding Patient-Centered R&D Challenges And Future Trends
  4. CorEvitas and Inovalon Announce Expansion of Patient-Centered RWD Partnership

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Sr. Manager of HEOR Analytics
  • Manager of Commercial Analytics
  • Assistant Director - Oncology Strategy & Communications (Remote)
  • Senior Director - Evidence Generation & Value Communications (Remote)
  • Medical Writer
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists